Table 3.
Trial primary safety outcome
| Primary safety outcome | Clopidogrel with Aspirin (n = 93) | Clopidogrel with Indobufen (n = 89) | χ2 | Hazard Ratio (95% CI) |
P |
|---|---|---|---|---|---|
| Bleeding(%) | 8(8.6) | 1(1.1) | - | 0.92 (0.87–0.99) | 0.035 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.